PCSK9 update

"These drugs are so expensive -- $14,000-$15,000 a year. Cardiologists have never been faced with a situation like this," said DeMaria, who noted that the prices quoted for the PCSK9 drugs were similar to the costs of cancer drugs but with an important difference: "these drugs are forever. Forever."

http://www.medpagetoday.com/Cardiology/Dyslipidemia/53451?xid=nl_mpt_DHE_2015-09-09&eun=g432148d0r